Description
DYZOSET-DSR Capsules
Pantoprazole 40 mg + Domperidone 30 mg (Sustained Release) Capsules
DYZOSET-DSR is a combination of Pantoprazole 40 mg and Domperidone 30 mg Sustained Release, formulated to provide effective acid suppression while supporting gastric motility. It is marketed by Medroots Biopharma, a PCD pharmaceutical company offering a broad portfolio of quality healthcare products across India.
Composition
Pantoprazole Sodium (Equivalent to Pantoprazole) IP – 40 mg
Domperidone Prolonged Release IP – 30 mg
Key Features
Dual-action formulation for acid-related disorders
Helps reduce excess stomach acid
Sustained-release Domperidone supports prolonged gastric motility
Quality-assured manufacturing
Attractive packaging suitable for PCD Pharma Franchise business
Common Clinical Uses
Under the supervision of a registered medical practitioner, DYZOSET-DSR may be prescribed for:
Gastroesophageal Reflux Disease (GERD)
Acid reflux
Hyperacidity
Gastritis
Peptic ulcer disease
Heartburn associated with excess gastric acid
How It Works
Pantoprazole is a proton pump inhibitor (PPI) that reduces gastric acid secretion by blocking the proton pump in the stomach.
Domperidone SR is a prokinetic agent that promotes gastric emptying and may help relieve symptoms such as nausea, bloating, and fullness associated with delayed gastric emptying.
Advantages
Effective control of gastric acid secretion
Long-lasting symptom relief with sustained-release technology
Supports improved gastric emptying
Convenient once-daily dosing when prescribed by a physician
Marketed By
Medroots Biopharma
A Trusted PCD Pharma Company committed to delivering quality, innovative, and affordable pharmaceutical products across India.
Disclaimer
DYZOSET-DSR is a prescription medicine. It should be used only under the guidance of a qualified healthcare professional. The information provided is for educational and promotional purposes and is not intended to replace medical advice.
